Senior insider sale
Chief Financial Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$553.0K
24.06K shares
What this filing means
HORN HOWARD plans to sell 24.06K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $553.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001950047-26-005347
Officer· Chief Financial Officer
Since Mar 2026
24.06K
Shares to sell
$553.0K
Approx. market value
4.65K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Performance and Restricted Stock
Not Applicable
10/9/2024
4.65KTotal acquired4.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/9/2024 | Performance and Restricted Stock Not Applicable | 4.65K | — |
| Total | 4.65K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
4.68K
Market value
$116.6K
5/1/2026
—Completed
Units to sell
4.68K
Market value
$98.2K
4/1/2026
—Completed
Units to sell
1.64K
Market value
$36.6K
3/3/2026
—Completed
Units to sell
3.12K
Market value
$70.3K
3/2/2026
—Completed
Units to sell
5.29K
Market value
$120.6K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.65K
Market value
$110.6K
6/1/2026
Total
Units
24.06K
Value
$553.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 4.68K | $116.6K | — | Completed |
4/1/2026 | 4.68K | $98.2K | — | Completed |
3/3/2026 | 1.64K | $36.6K | — | Completed |
3/2/2026 | 3.12K | $70.3K | — | Completed |
3/2/2026 | 5.29K | $120.6K | — | Completed |
| Planned — Approximate Date | ||||
6/1/2026 | 4.65K | $110.6K | NASDAQ | Planned |
| Total | 24.06K | $553.0K | ||